Searched for
EXTENDED RELEASE TABLETS
Alembic Pharmaceuticals gets USFDA nod for generic Carbamazepine tabletsAlembic Pharmaceuticals has received final approval from the USFDA for its generic Carbamazepine extended-release tablets (100 mg, 200 mg, ...
Zydus Lifesciences gets USFDA nod for generic cholesterol lowering drugZydus Lifesciences Ltd. has secured final USFDA approval to manufacture generic Niacin extended-release tablets in 500 mg, 750 mg, and 1,00...
Zydus gets US nod for schizophrenia generic medicineZydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are...
Alembic Pharma gets USFDA nod for generic drug used to treat schizophreniaAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Paliperidone extended-release tablets, used t...
Strides gets USFDA nod for Theophylline extended-release tabletsStrides Pharma Science Ltd announced that its subsidiary has received approval from the USFDA for its generic version of Theophylline exten...
Zydus Lifesciences gets USFDA nod for asthma treatment drugZydus Lifesciences Ltd receives final USFDA approval to market generic Theophylline extended-release tablets of strengths 300 mg and 450 mg...
Zydus Lifesciences launches generic drug for overactive bladder in US marketZydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market. The c...
Lupin gets USFDA nod for generic medicationThe company has received approval from the US Food and Drug Administration to market Fesoterodine Fumarate extended-release tablets in stre...
Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate extended-release tabletsThe approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for fesoterodine fumarate extende...
Lupin recalls diabetes treatment drug in USDrug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tab...
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemicalThe company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitroso...
Granules India gets tentative nod from USFDA for expectorant tabletsGranules India stock was trading at Rs 162.65 apiece, up 2.07 per cent, on the BSE.
Lupin gets USFDA nod to market its mania and epilepsy treatment drug in USThe company has received approval from the United States Food and Drug Administration (USFDA) for its Divalproex Sodium extended-release ta...
Glenmark gets final nod from USFDA for angina treatment drugThe product is a generic version of Gilead Sciences Inc's Ranexa extended-release tablets in the same strengths.
Cipla gets USFDA nod for overactive bladder treating drug"We have received final approval for ANDA for Darifenacin extended-release tablets, 7.5 mg and 15mg, from USFDA," a company statement said ...
Unichem gets USFDA approval to sell prostate drugUnichem Laboratories has received approval from the US health regulator to market alfuzosin hydrochloride extended release tablets, used in...
- Sun Pharma receives USFDA nod for Venlafaxine tablets
Sun Pharmaceuticals Industries Ltd has received USFDA's approval to market a generic version of Venlafaxine Hydrochloride Extended Release ...